KRYSTAL BIOTECH INC's ticker is KRYS and the CUSIP is 501147102. A total of 113 filers reported holding KRYSTAL BIOTECH INC in Q2 2020. The put-call ratio across all filers is 1.08 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $7,216,708 | +1049.2% | 62,213 | +1063.1% | 0.25% | +1000.0% |
| Q2 2023 | $627,973 | +190.6% | 5,349 | +98.2% | 0.02% | +155.6% |
| Q1 2023 | $216,082 | -85.9% | 2,699 | -86.0% | 0.01% | -88.0% |
| Q4 2022 | $1,530,451 | +121.2% | 19,319 | +94.6% | 0.08% | +127.3% |
| Q3 2022 | $692,000 | -24.7% | 9,927 | -29.0% | 0.03% | -26.7% |
| Q2 2022 | $919,000 | -56.7% | 13,990 | -56.1% | 0.04% | -53.6% |
| Q1 2022 | $2,120,000 | +544.4% | 31,859 | +405.7% | 0.10% | +506.2% |
| Q3 2021 | $329,000 | -55.8% | 6,300 | -42.5% | 0.02% | -44.8% |
| Q2 2021 | $745,000 | -11.1% | 10,951 | +0.7% | 0.03% | +7.4% |
| Q1 2021 | $838,000 | -14.9% | 10,875 | -33.8% | 0.03% | -46.0% |
| Q4 2020 | $985,000 | -32.1% | 16,418 | -51.2% | 0.05% | -49.0% |
| Q3 2020 | $1,450,000 | -22.5% | 33,672 | -25.5% | 0.10% | -15.5% |
| Q2 2020 | $1,872,000 | – | 45,202 | – | 0.12% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Redmile Group, LLC | 1,913,280 | $153,177,197 | 6.65% |
| Frazier Life Sciences Management, L.P. | 945,407 | $75,689,284 | 5.48% |
| S Squared Technology, LLC | 108,215 | $8,663,693 | 5.14% |
| Nicholas Investment Partners, LP | 374,718 | $29,999,923 | 2.28% |
| Avoro Capital Advisors LLC | 1,750,000 | $140,105,000 | 2.08% |
| Artal Group S.A. | 412,082 | $32,991 | 1.96% |
| First Light Asset Management, LLC | 195,980 | $15,690,159 | 1.41% |
| Integral Health Asset Management, LLC | 85,000 | $6,805,100 | 1.37% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 61,000 | $4,883,660 | 1.36% |
| Hood River Capital Management LLC | 447,393 | $35,818,000 | 1.16% |